Cambridge Investment Research Advisors Inc. Has $11.54 Million Position in KKR & Co. Inc. (NYSE:KKR)

Cambridge Investment Research Advisors Inc. cut its position in KKR & Co. Inc. (NYSE:KKR) by 0.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 99,806 shares of the asset manager’s stock after selling 840 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in KKR & Co. Inc. were worth $11,539,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Oppenheimer Asset Management Inc. boosted its stake in shares of KKR & Co. Inc. by 0.4% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 16,427 shares of the asset manager’s stock valued at $2,430,000 after purchasing an additional 69 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of KKR & Co. Inc. by 5.7% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,289 shares of the asset manager’s stock valued at $191,000 after purchasing an additional 70 shares during the last quarter. Edge Capital Group LLC boosted its stake in shares of KKR & Co. Inc. by 3.9% in the 4th quarter. Edge Capital Group LLC now owns 2,058 shares of the asset manager’s stock valued at $304,000 after purchasing an additional 78 shares during the last quarter. LRI Investments LLC boosted its stake in shares of KKR & Co. Inc. by 9.9% in the 4th quarter. LRI Investments LLC now owns 1,110 shares of the asset manager’s stock valued at $164,000 after purchasing an additional 100 shares during the last quarter. Finally, Lindbrook Capital LLC boosted its stake in shares of KKR & Co. Inc. by 3.3% in the 4th quarter. Lindbrook Capital LLC now owns 3,179 shares of the asset manager’s stock valued at $470,000 after purchasing an additional 102 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

KKR has been the topic of a number of analyst reports. Keefe, Bruyette & Woods upped their price objective on shares of KKR & Co. Inc. from $129.00 to $131.00 and gave the company an “outperform” rating in a research note on Friday, May 2nd. HSBC upgraded shares of KKR & Co. Inc. from a “hold” rating to a “buy” rating and dropped their target price for the company from $170.00 to $119.00 in a research report on Tuesday, April 15th. Barclays boosted their target price on shares of KKR & Co. Inc. from $129.00 to $141.00 and gave the company an “overweight” rating in a research report on Friday, May 2nd. Morgan Stanley upgraded shares of KKR & Co. Inc. from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $120.00 to $150.00 in a research report on Wednesday, May 14th. Finally, Wells Fargo & Company boosted their target price on shares of KKR & Co. Inc. from $136.00 to $140.00 and gave the company an “overweight” rating in a research report on Friday, May 23rd. One investment analyst has rated the stock with a sell rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $149.43.

KKR & Co. Inc. Stock Performance

KKR opened at $127.78 on Wednesday. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.77. The company’s fifty day moving average price is $118.50 and its two-hundred day moving average price is $129.80. KKR & Co. Inc. has a 1-year low of $86.15 and a 1-year high of $170.40. The company has a market cap of $113.81 billion, a price-to-earnings ratio of 53.92, a PEG ratio of 1.36 and a beta of 1.89.

KKR & Co. Inc. (NYSE:KKR) last released its quarterly earnings data on Thursday, May 1st. The asset manager reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.02. KKR & Co. Inc. had a net margin of 14.75% and a return on equity of 6.43%. The firm had revenue of $1.77 billion for the quarter, compared to the consensus estimate of $1.71 billion. During the same quarter in the prior year, the company posted $0.97 earnings per share. The business’s revenue was down 67.8% on a year-over-year basis. On average, analysts expect that KKR & Co. Inc. will post 5.19 EPS for the current fiscal year.

KKR & Co. Inc. Increases Dividend

The firm also recently disclosed a dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were issued a dividend of $0.185 per share. This is an increase from KKR & Co. Inc.’s previous dividend of $0.17. The ex-dividend date was Monday, May 12th. This represents a yield of 0.64%. KKR & Co. Inc.’s dividend payout ratio is presently 31.22%.

Insiders Place Their Bets

In other news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $34.20, for a total value of $205,200,000.00. Following the completion of the sale, the insider now owns 13,260,971 shares in the company, valued at $453,525,208.20. This represents a 31.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Chairman George R. Roberts sold 1,190,094 shares of the stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $119.80, for a total transaction of $142,573,261.20. Following the completion of the sale, the chairman now owns 82,171,884 shares of the company’s stock, valued at approximately $9,844,191,703.20. This represents a 1.43% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 8,471,488 shares of company stock worth $501,529,092. Insiders own 39.34% of the company’s stock.

About KKR & Co. Inc.

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.